Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Integrated assessment of CDK1 upregulation in thyroid cancer.

Zheng HP, Huang ZG, He RQ, Lu HP, Dang YW, Lin P, Wen DY, Qin YY, Luo B, Li XJ, Mo WJ, Yang H, He Y, Chen G.

Am J Transl Res. 2019 Dec 15;11(12):7233-7254. eCollection 2019.

3.

Preoperative Ultrasound Radiomics Signatures for Noninvasive Evaluation of Biological Characteristics of Intrahepatic Cholangiocarcinoma.

Peng YT, Zhou CY, Lin P, Wen DY, Wang XD, Zhong XZ, Pan DH, Que Q, Li X, Chen L, He Y, Yang H.

Acad Radiol. 2019 Sep 4. pii: S1076-6332(19)30383-6. doi: 10.1016/j.acra.2019.07.029. [Epub ahead of print]

PMID:
31494003
4.

A radiogenomics signature for predicting the clinical outcome of bladder urothelial carcinoma.

Lin P, Wen DY, Chen L, Li X, Li SH, Yan HB, He RQ, Chen G, He Y, Yang H.

Eur Radiol. 2020 Jan;30(1):547-557. doi: 10.1007/s00330-019-06371-w. Epub 2019 Aug 8.

PMID:
31396730
5.

Oncogenic value of microRNA-15b-5p in hepatocellular carcinoma and a bioinformatics investigation.

Pan WY, Zeng JH, Wen DY, Wang JY, Wang PP, Chen G, Feng ZB.

Oncol Lett. 2019 Feb;17(2):1695-1713. doi: 10.3892/ol.2018.9748. Epub 2018 Nov 22.

6.

Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data.

Wen DY, Huang JC, Wang JY, Pan WY, Zeng JH, Pang YY, Yang H.

Oncol Lett. 2018 Dec;16(6):6918-6929. doi: 10.3892/ol.2018.9523. Epub 2018 Sep 28.

7.

Exploration of the diagnostic value and molecular mechanism of miR‑1 in prostate cancer: A study based on meta‑analyses and bioinformatics.

Xie ZC, Huang JC, Zhang LJ, Gan BL, Wen DY, Chen G, Li SH, Yan HB.

Mol Med Rep. 2018 Dec;18(6):5630-5646. doi: 10.3892/mmr.2018.9598. Epub 2018 Oct 25.

8.

A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma.

Xiong DD, Dang YW, Lin P, Wen DY, He RQ, Luo DZ, Feng ZB, Chen G.

J Transl Med. 2018 Aug 9;16(1):220. doi: 10.1186/s12967-018-1593-5.

9.

Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.

Lin P, Wen DY, Li Q, He Y, Yang H, Chen G.

Cell Physiol Biochem. 2018;48(5):1953-1967. doi: 10.1159/000492519. Epub 2018 Aug 9.

10.

Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.

Wen DY, Pan DH, Lin P, Mo QY, Wei YP, Luo YH, Chen G, He Y, Chen JQ, Yang H.

Mol Med Rep. 2018 Sep;18(3):2631-2642. doi: 10.3892/mmr.2018.9247. Epub 2018 Jul 3.

11.

A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.

Zhang Y, Wen DY, Zhang R, Huang JC, Lin P, Ren FH, Wang X, He Y, Yang H, Chen G, Luo DZ.

Cell Physiol Biochem. 2018;47(6):2216-2232. doi: 10.1159/000491534. Epub 2018 Jul 5.

12.

Comprehensive and Integrative Analysis Reveals the Diagnostic, Clinicopathological and Prognostic Significance of Polo-Like Kinase 1 in Hepatocellular Carcinoma.

Lin P, Wen DY, Dang YW, He Y, Yang H, Chen G.

Cell Physiol Biochem. 2018;47(3):925-947. doi: 10.1159/000490135. Epub 2018 May 24.

13.

Up-regulation of CTD-2547G23.4 in hepatocellular carcinoma tissues and its prospective molecular regulatory mechanism: a novel qRT-PCR and bioinformatics analysis study.

Wen DY, Lin P, Liang HW, Yang X, Li HY, He Y, Yang H, Chen G.

Cancer Cell Int. 2018 May 11;18:74. doi: 10.1186/s12935-018-0566-3. eCollection 2018.

14.

Comprehensive analysis of the clinical significance and prospective molecular mechanisms of differentially expressed autophagy-related genes in thyroid cancer.

Lin P, He Y, Wen DY, Li XJ, Zeng JJ, Mo WJ, Li Q, Peng JB, Wu YQ, Pan DH, Li HY, Mo QY, Wei YP, Yang H, Chen G.

Int J Oncol. 2018 Aug;53(2):603-619. doi: 10.3892/ijo.2018.4404. Epub 2018 May 11.

16.

An autophagy-related gene expression signature for survival prediction in multiple cohorts of hepatocellular carcinoma patients.

Lin P, He RQ, Dang YW, Wen DY, Ma J, He Y, Chen G, Yang H.

Oncotarget. 2018 Jan 9;9(25):17368-17395. doi: 10.18632/oncotarget.24089. eCollection 2018 Apr 3.

17.

Clinical significance of microRNA-449a in hepatocellular carcinoma with microarray data mining together with initial bioinformatics analysis.

Yang X, Wang HL, Liang HW, Liang L, Wen DY, Zhang R, Chen G, Wei DM.

Exp Ther Med. 2018 Apr;15(4):3247-3258. doi: 10.3892/etm.2018.5836. Epub 2018 Feb 5.

18.

The protective value of miR-204-5p for prognosis and its potential gene network in various malignancies: a comprehensive exploration based on RNA-seq high-throughput data and bioinformatics.

Ye ZH, Wen DY, Cai XY, Liang L, Wu PR, Qin H, Yang H, He Y, Chen G.

Oncotarget. 2017 Oct 23;8(62):104960-104980. doi: 10.18632/oncotarget.21950. eCollection 2017 Dec 1.

19.

The anticipating value of PLK1 for diagnosis, progress and prognosis and its prospective mechanism in gastric cancer: a comprehensive investigation based on high-throughput data and immunohistochemical validation.

Lin P, Xiong DD, Dang YW, Yang H, He Y, Wen DY, Qin XG, Chen G.

Oncotarget. 2017 Sep 30;8(54):92497-92521. doi: 10.18632/oncotarget.21438. eCollection 2017 Nov 3.

20.

Utility of miR‑133a‑3p as a diagnostic indicator for hepatocellular carcinoma: An investigation combined with GEO, TCGA, meta‑analysis and bioinformatics.

Liang HW, Yang X, Wen DY, Gao L, Zhang XY, Ye ZH, Luo J, Li ZY, He Y, Pang YY, Chen G.

Mol Med Rep. 2018 Jan;17(1):1469-1484. doi: 10.3892/mmr.2017.8040. Epub 2017 Nov 14.

21.

RNA-sequencing investigation identifies an effective risk score generated by three novel lncRNAs for the survival of papillary thyroid cancer patients.

Luo YH, Liang L, He RQ, Wen DY, Deng GF, Yang H, He Y, Ma W, Cai XY, Chen JQ, Chen G.

Oncotarget. 2017 May 26;8(43):74139-74158. doi: 10.18632/oncotarget.18274. eCollection 2017 Sep 26.

22.

Downregulation of miR‑136‑5p in hepatocellular carcinoma and its clinicopathological significance.

Ding H, Ye ZH, Wen DY, Huang XL, Zeng CM, Mo J, Jiang YQ, Li JJ, Cai XY, Yang H, Chen G.

Mol Med Rep. 2017 Oct;16(4):5393-5405. doi: 10.3892/mmr.2017.7275. Epub 2017 Aug 17.

23.

The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases.

Pan DH, Wen DY, Luo YH, Chen G, Yang H, Chen JQ, He Y.

Onco Targets Ther. 2017 Jul 3;10:3261-3276. doi: 10.2147/OTT.S135593. eCollection 2017. Review.

24.

Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas.

Ye ZH, Gao L, Wen DY, He Y, Pang YY, Chen G.

Onco Targets Ther. 2017 Mar 21;10:1711-1723. doi: 10.2147/OTT.S132120. eCollection 2017.

25.

Overexpression of LncRNA HOTAIR is Associated with Poor Prognosis in Thyroid Carcinoma: A Study Based on TCGA and GEO Data.

Li HM, Yang H, Wen DY, Luo YH, Liang CY, Pan DH, Ma W, Chen G, He Y, Chen JQ.

Horm Metab Res. 2017 May;49(5):388-399. doi: 10.1055/s-0043-103346. Epub 2017 Mar 28.

PMID:
28351094
26.

From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma.

Yang H, Zhang X, Cai XY, Wen DY, Ye ZH, Liang L, Zhang L, Wang HL, Chen G, Feng ZB.

PeerJ. 2017 Mar 14;5:e3089. doi: 10.7717/peerj.3089. eCollection 2017.

27.

Preparation of fucoidan-shelled and genipin-crosslinked chitosan beads for antibacterial application.

Yu SH, Wu SJ, Wu JY, Wen DY, Mi FL.

Carbohydr Polym. 2015 Aug 1;126:97-107. doi: 10.1016/j.carbpol.2015.02.068. Epub 2015 Mar 14.

PMID:
25933528
28.

Collapsed athlete - atraumatic.

Wen DY.

Curr Rev Musculoskelet Med. 2014 Dec;7(4):348-54. doi: 10.1007/s12178-014-9238-7.

29.

Musculocutaneous nerve injury in a high school pitcher.

Stephens L, Kinderknecht JJ, Wen DY.

Clin J Sport Med. 2014 Nov;24(6):e68-9. doi: 10.1097/JSM.0000000000000083.

PMID:
24569491
30.

Letter to the editor and response.

Wen DY, Schultz BJ, Schaal B, Graham ST, Kim BS.

Sports Health. 2013 Jul;5(4):307. doi: 10.1177/1941738113491385. No abstract available.

31.

A computational bioinformatics analysis of gene expression identifies candidate agents for prostate cancer.

Wen DY, Geng J, Li W, Guo CC, Zheng JH.

Andrologia. 2014 Aug;46(6):625-32. doi: 10.1111/and.12127. Epub 2013 Jun 24.

PMID:
23790256
32.

Eccentric strengthening for chronic lateral epicondylosis: a prospective randomized study.

Wen DY, Schultz BJ, Schaal B, Graham ST, Kim BS.

Sports Health. 2011 Nov;3(6):500-3.

33.

Scaphoid fractures with unusual presentations: a case series.

Pandit S, Wen DY.

Cases J. 2009 Jul 23;2:7220. doi: 10.4076/1757-1626-2-7220.

34.

Ultrasonographic evaluation of splenic enlargement in athletes with acute infectious mononucleosis.

Hosey RG, Kriss V, Uhl TL, DiFiori J, Hecht S, Wen DY.

Br J Sports Med. 2008 Dec;42(12):974-7. doi: 10.1136/bjsm.2008.050807. Epub 2008 Sep 18.

PMID:
18801776
35.

Risk factors for overuse injuries in runners.

Wen DY.

Curr Sports Med Rep. 2007 Oct;6(5):307-13. Review.

PMID:
17883966
36.

MRI description of knee medial collateral ligament abnormalities in the absence of trauma: edema related to osteoarthritis and medial meniscal tears.

Wen DY, Propeck T, Kane SM, Godbee MT, Rall KL.

Magn Reson Imaging. 2007 Feb;25(2):209-14. Epub 2006 Nov 13.

PMID:
17275615
37.

[The application and biological improvement of amniotic membrane].

Wen DY, Yuan J, Chen JQ.

Zhonghua Yan Ke Za Zhi. 2006 Apr;42(4):361-4. Review. Chinese.

PMID:
16762223
38.

Approach to shoulder pain in primary care.

Wen DY.

Mo Med. 2006 Mar-Apr;103(2):169-74. Review.

PMID:
16703719
39.

Preparticipation cardiovascular screening of young athletes: an epidemiologic perspective.

Wen DY.

Phys Sportsmed. 2004 Jun;32(6):23-30. doi: 10.3810/psm.2004.06.387.

PMID:
20086414
40.

Deep vein thrombosis of the subclavian vein in a college volleyball player.

Treat SD, Smith PA, Wen DY, Kinderknecht JJ.

Am J Sports Med. 2004 Mar;32(2):529-32. No abstract available.

PMID:
14977686
41.

Atrial flutter in a college football player: return to play or not?

Wen DY, Flaker G, Sharp RL, Smith PA.

Phys Sportsmed. 2003 Oct;31(10):21-35. doi: 10.3810/psm.2003.10.524.

PMID:
20086434
42.

Femoral neck stress injury with negative bone scan.

Wen DY, Propeck T, Singh A.

J Am Board Fam Pract. 2003 Mar-Apr;16(2):170-4. No abstract available.

43.

Intra-articular hyaluronic acid injections for knee osteoarthritis.

Wen DY.

Am Fam Physician. 2000 Aug 1;62(3):565-70, 572. Review.

44.

Current concepts in the treatment of anterior shoulder dislocations.

Wen DY.

Am J Emerg Med. 1999 Jul;17(4):401-7. Review.

PMID:
10452444
45.

Complications of subcutaneous low-dose heparin therapy in neurosurgical patients.

Wen DY, Hall WA.

Surg Neurol. 1998 Dec;50(6):521-5.

PMID:
9870811
46.

Injuries in runners: a prospective study of alignment.

Wen DY, Puffer JC, Schmalzried TP.

Clin J Sport Med. 1998 Jul;8(3):187-94.

PMID:
9762477
47.

Lower extremity alignment and risk of overuse injuries in runners.

Wen DY, Puffer JC, Schmalzried TP.

Med Sci Sports Exerc. 1997 Oct;29(10):1291-8.

PMID:
9346158
48.

Intracranial aneurysm rupture presenting as delayed stroke secondary to cerebral vasospasm.

Nussbaum ES, Sebring LA, Wen DY.

Stroke. 1997 Oct;28(10):2078-80.

PMID:
9341721
50.

Meningeal sarcoma mimicking an acute subdural hematoma on CT.

Nussbaum ES, Wen DY, Latchaw RE, Nelson MJ.

J Comput Assist Tomogr. 1995 Jul-Aug;19(4):643-5.

PMID:
7622702

Supplemental Content

Support Center